Facebook
X
LinkedIn
ForwardMaternal Depression and Substance Use Disorder Screening; Before, During and After Birth and Discharge
This presentation was recorded during the live meeting titled "Kentucky Symposium for Maternal and Infant Outcomes" on September 12, 2024. If you attended that event and claimed credit you should not claim credit for this module.
Screenings for issues that greatly impact maternal morbidity and mortality occur during the prenatal visits and during the hospital admissions/stay.
What are the risks associated with the timing of current screenings?
- No prenatal care
- Admission screens decrease the options for assistance
- During hospital stay screens miss the high risk time (between 7-14 days postpartum)
- Missed postpartum outpatient visits
- Less than optimal communication between ambulatory and inpatient setting
Target Audience
This course targets physicians, midwives, advanced nurse practitioners, nurses, community health workers, peer support specialists, social workers, doulas, emergency medical technicians, pharmacists, public health officials, and dentists.
Learning Objectives
Upon completion of this activity, participants will be able to:
- Discuss the process of maternal depression and substance use screening in the acute care setting.
- Discuss the process of maternal depression and substance use screening post discharge from acute care setting.
- Identify screening tools for screening of maternal depression and substance use disorder.
- Describe past cases and outcomes of positive screening identified in acute care or post-discharge/home setting.
Faculty & Credentials
Rita Crum, MSN, RN, HACP
Women's and Children's Health Service Line Director
Appalachian Regional Healthcare
Allison E. Webb, BSN, RN, SANE
Head Nurse Manager
Labor & Delivery, Postpartum, and Newborn Nursery Units
Harlan ARH Hospital
Harlan, Kentucky.
Disclosure Information
All planners, faculty, and others in control of educational content are required to disclose all their financial relationships with ineligible companies within the prior 24 months. An ineligible company is defined as one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company.
None of the planners, faculty, and others in control of educational content for this educational activity have relevant financial relationship(s) to disclose with ineligible companies.
The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.
Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.
In support of improving patient care, University of Kentucky HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Available Credit
- 1.50 AMA PRA Category 1 Credit™
In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.
This Enduring activity is designated for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
- 1.50 ANCC (UK Healthcare CECentral)
In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.50 nursing contact hour(s).
- 1.50 ASWB
As a Jointly Accredited Organization, UK HealthCare CECentral is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. UK HealthCare CECentral maintains responsibility for this course.
Social workers completing this course receive 1.50 clinical continuing education credit(s).
- 1.50 Certified Community Health WorkThis training is approved by the Office of Community Health Workers Program to provide 1.50 continuing education unit(s) for Certified Community Health Workers.
- 1.50 Public HealthUniversity of Kentucky College of Public Health certifies that this educational activity was designated for 1.50 hour(s) of Public Health Continuing Education (CPHCE) credit. This course is approved for continuing education by the University of Kentucky College of Public Health.